Biotech High-Flyers That Just Hit 52-Week Highs

(RTTNews) - In the biotech investment landscape, staying ahead of the curve is key to unlocking potential gains. The following biotech stocks, featured on our site, hit 52-week highs recently. Please note that the list is not exhaustive, and it represents merely a fraction of the high-performing stocks we have profiled.

*Last Closing Price refers to the stock's closing price on Feb.2, 2024.

Ticker

Published Date

Published Price

Maximum Price Since Publication

*Last Closing Price

Maximum Gain %

Cullinan Oncology, Inc. (CGEM)

May 26, 2023

$9.54

$18.10

$17.75

89%

Edgewise Therapeutics Inc. (EWTX)

Oct.16, 2023

$6.71

$19.50

$18.55

190%

Vera Therapeutics Inc. (VERA)

Jan.22, 2024

$15.52

$39.62

$39.15

155%

Alpine Immune Sciences, Inc. (ALPN)

Mar.3, 2023

$7.97

$28.44

$27.69

256%

KalVista Pharma (KALV)

Jan.2, 2024

$12.53

$16.88

$15.22

35%

EyePoint Pharmaceuticals Inc. (EYPT)

Aug.1, 2023

$12.35

$29.42

$28.70

138%

RxSight, Inc. (RXST

Jul.10, 2023

$31.30

$50.20

$47.24

60%

Tarsus Pharmaceuticals, Inc. (TARS)

Nov.29, 2023

$16.56

$29.68

$28.54

79%

Ironwood Pharmaceuticals Inc. (IRWD)

Dec.19, 2023

$11.22

$14.76

$14.59

31%

IDEAYA Biosciences Inc. (IDYA)

June 5, 2023

$24.71

$45

$44.33

82%

Pulmonx Corp. (LUNG)

Oct.31, 2023

$8.75

$14.49

$14.26

65%

Ascendis Pharma A/S (ASND)

Dec.15, 2023

$121.17

$143.76

$139.77

18%

Spruce Biosciences, Inc. (SPRB)

Jan.25, 2024

$2.57

$3.90

$3.52

51%

Alvotech (ALVO)

Nov.21, 2023

$8.95

$16.10

$15.70

79%

Y-mAbs Therapeutics Inc. (YMAB) 

Sep.15, 2023

$4.99

$14.07

$14.00

182%

Relmada Therapeutics Inc. (RLMD)

Sep.11, 2023

$3.55

$4.84

$4.60

36%

SpringWorks Therapeutics Inc. (SWTX) 

Nov.28, 2023

$23

$47.11

$46.15

105%

MorphoSys AG (MOR)

June 6, 2023

$7.04

$11.80

$11.07

67%

RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source

Tags

Latest Articles

Data is currently not available